ro7616789
Showing 1 - 1 of 1
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)
Recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
- RO7616789
- Tocilizumab
-
Chiba, Japan
- +1 more
Jan 16, 2023